Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Effects of production methods and protective ingredients on the viability of probiotic Lactobacillus rhamnosus R0011 in air-dried alginate beads.

Champagne CP, Raymond Y, Arcand Y.

Can J Microbiol. 2017 Jan;63(1):35-45. doi: 10.1139/cjm-2016-0349. Epub 2016 Aug 26.

PMID:
27900876
2.

Effects of High Doses of Vitamin C on Cancer Patients in Singapore: Nine Cases.

Raymond YC, Glenda CS, Meng LK.

Integr Cancer Ther. 2016 Jun;15(2):197-204. doi: 10.1177/1534735415622010. Epub 2015 Dec 17.

3.

Impact of a yogurt matrix and cell microencapsulation on the survival of Lactobacillus reuteri in three in vitro gastric digestion procedures.

Champagne CP, Raymond Y, Guertin N, Martoni CJ, Jones ML, Mainville I, Arcand Y.

Benef Microbes. 2015;6(5):753-63. doi: 10.3920/BM2014.0162. Epub 2015 Jun 3.

PMID:
26036146
4.

The use of flow cytometry to accurately ascertain total and viable counts of Lactobacillus rhamnosus in chocolate.

Raymond Y, Champagne CP.

Food Microbiol. 2015 Apr;46:176-183. doi: 10.1016/j.fm.2014.07.002. Epub 2014 Jul 10.

PMID:
25475282
5.

Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .

Zoufaly A, Jochum J, Hammerl R, Nassimi N, Raymond Y, Burchard GD, Schmiedel S, Drexler JF, Campbell NK, Taka N, Awasom C, Metzner KJ, van Lunzen J, Feldt T.

J Antimicrob Chemother. 2015 Mar;70(3):922-5. doi: 10.1093/jac/dku470. Epub 2014 Nov 26.

6.

Determinants of HIV-1 drug resistance in treatment-naïve patients and its clinical implications in an antiretroviral treatment program in Cameroon.

Zoufaly A, Jochum J, Hammerl R, Nassimi N, Raymond Y, Burchard GD, Schmiedel S, Drexler JF, Kay CN, Taka N, Awasom C, Metzner K, Jan vL, Feldt T.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19615. doi: 10.7448/IAS.17.4.19615. eCollection 2014.

7.

Effect of bovine colostrum, cheese whey, and spray-dried porcine plasma on the in vitro growth of probiotic bacteria and Escherichia coli.

Champagne CP, Raymond Y, Pouliot Y, Gauthier SF, Lessard M.

Can J Microbiol. 2014 May;60(5):287-95. doi: 10.1139/cjm-2014-0130. Epub 2014 Mar 18.

PMID:
24773334
8.
9.

Effect of water activity and protective solutes on growth and subsequent survival to air-drying of Lactobacillus and Bifidobacterium cultures.

Champagne CP, Raymond Y, Simon JP.

Appl Microbiol Biotechnol. 2012 Aug;95(3):745-56. doi: 10.1007/s00253-012-3912-8. Epub 2012 Feb 22.

PMID:
22350318
10.

Heparin inhibits the interaction of DNA topoisomerase I/anti-topoisomerase I immune complexes with heparan sulfate on dermal fibroblasts.

Arcand J, Robitaille G, Koenig M, Senécal JL, Raymond Y.

Arthritis Rheum. 2012 May;64(5):1632-41. doi: 10.1002/art.33484.

11.

The autoantigen DNA topoisomerase I interacts with chemokine receptor 7 and exerts cytokine-like effects on dermal fibroblasts.

Arcand J, Robitaille G, Koenig M, Senécal JL, Raymond Y.

Arthritis Rheum. 2012 Mar;64(3):826-34. doi: 10.1002/art.33377.

12.

Decreased secretion of MMP by non-lesional late-stage scleroderma fibroblasts after selection via activation of the apoptotic Fas-pathway.

Chabaud S, Corriveau MP, Grodzicky T, Senécal JL, Chartier S, Raymond Y, Moulin VJ.

J Cell Physiol. 2011 Jul;226(7):1907-14. doi: 10.1002/jcp.22520.

PMID:
21506121
13.

The determination of viable counts in probiotic cultures microencapsulated by spray-coating.

Champagne CP, Raymond Y, Tompkins TA.

Food Microbiol. 2010 Dec;27(8):1104-11. doi: 10.1016/j.fm.2010.07.017. Epub 2010 Jul 24.

PMID:
20832691
14.

Immunomodulatory properties of fermented soy and dairy milks prepared with lactic acid bacteria.

Wagar LE, Champagne CP, Buckley ND, Raymond Y, Green-Johnson JM.

J Food Sci. 2009 Oct;74(8):M423-30. doi: 10.1111/j.1750-3841.2009.01308.x.

PMID:
19799669
15.

Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells.

Robitaille G, Christin MS, Clément I, Senécal JL, Raymond Y.

Arthritis Rheum. 2009 Sep;60(9):2805-16. doi: 10.1002/art.24765.

16.

Enumeration of the contaminating bacterial microbiota in unfermented pasteurized milks enriched with probiotic bacteria.

Champagne CP, Raymond Y, Gonthier J, Audet P.

Can J Microbiol. 2009 Apr;55(4):410-8. doi: 10.1139/w08-151.

PMID:
19396241
17.

The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.

Corriveau MP, Boufaied I, Lessard J, Chabaud S, Senécal JL, Grodzicky T, Chartier S, Raymond Y, Moulin VJ.

J Pathol. 2009 Mar;217(4):534-42. doi: 10.1002/path.2482.

PMID:
19086038
18.

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.

Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senécal JL.

Arthritis Rheum. 2008 Dec;58(12):3902-12. doi: 10.1002/art.24038.

19.

Viability of Lactobacillus rhamnosus R0011 in an apple-based fruit juice under simulated storage conditions at the consumer level.

Champagne CP, Raymond Y, Gagnon R.

J Food Sci. 2008 Jun;73(5):M221-6. doi: 10.1111/j.1750-3841.2008.00775.x.

PMID:
18577004
20.

The nuclear autoantigen CENP-B displays cytokine-like activities toward vascular smooth muscle cells.

Robitaille G, Hénault J, Christin MS, Senécal JL, Raymond Y.

Arthritis Rheum. 2007 Nov;56(11):3814-26.

22.

The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).

Senécal JL, Hénault J, Raymond Y.

J Rheumatol. 2005 Sep;32(9):1643-9. No abstract available.

PMID:
16142854
23.

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.

Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL.

Medicine (Baltimore). 2005 Jul;84(4):231-49.

24.

Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis.

Laplante P, Raymond MA, Gagnon G, Vigneault N, Sasseville AM, Langelier Y, Bernard M, Raymond Y, Hébert MJ.

J Immunol. 2005 May 1;174(9):5740-9.

25.
27.

Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.

Hénault J, Tremblay M, Clément I, Raymond Y, Senécal JL.

Arthritis Rheum. 2004 Oct;50(10):3265-74.

28.
29.

Autoantibodies to NOR 90/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response.

Dagher JH, Scheer U, Voit R, Grummt I, Lonzetti L, Raymond Y, Senécal JL.

J Rheumatol. 2002 Jul;29(7):1543-7. Review.

PMID:
12136917
30.

Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival.

Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, Raymond Y, Senécal JL.

Medicine (Baltimore). 2002 Mar;81(2):154-67. No abstract available.

31.

Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma.

Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, Choquette D, Raymond Y, Senécal JL.

Arthritis Rheum. 2001 Mar;44(3):735-6. No abstract available.

32.

Evaluation of adenosine deaminase activity in the Mycobacterium tuberculosis culture supernatants.

Bañales JL, Rivera-Martínez E, Pérez-González L, Selman M, Raymond Y, Nava A.

Arch Med Res. 1999 Sep-Oct;30(5):358-9.

PMID:
10596453
33.

Spatial distribution of lamin A and B1 in the K562 cell nuclear matrix stabilized with metal ions.

Neri LM, Raymond Y, Giordano A, Borgatti P, Marchisio M, Capitani S, Martelli AM.

J Cell Biochem. 1999 Oct 1;75(1):36-45.

PMID:
10462702
34.

Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.

Senécal JL, Rauch J, Grodzicky T, Raynauld JP, Uthman I, Nava A, Guimond M, Raymond Y.

Arthritis Rheum. 1999 Jul;42(7):1347-53.

35.

Lamin A is part of the internal nucleoskeleton of human erythroleukemia cells.

Neri LM, Raymond Y, Giordano A, Capitani S, Martelli AM.

J Cell Physiol. 1999 Mar;178(3):284-95.

PMID:
9989774
36.

Chromatin condensation is not associated with apoptosis.

Hendzel MJ, Nishioka WK, Raymond Y, Allis CD, Bazett-Jones DP, Th'ng JP.

J Biol Chem. 1998 Sep 18;273(38):24470-8.

37.

Anti-heart autoantibodies are more frequently present in Chagas disease patients with dilated cardiomyopathy.

Nava A, Reyes PA, Monteón V, Raymond Y.

Am J Cardiol. 1997 Dec 15;80(12):1646-7. No abstract available.

PMID:
9416965
38.

Distinct nuclear assembly pathways for lamins A and C lead to their increase during quiescence in Swiss 3T3 cells.

Pugh GE, Coates PJ, Lane EB, Raymond Y, Quinlan RA.

J Cell Sci. 1997 Oct;110 ( Pt 19):2483-93.

39.

On the correct determination of reference values for serum antibodies against pigeon serum antigen using a group of healthy blood donors.

Bañales JL, Vázquez L, Mendoza F, Baltazares M, Raymond Y, Nava A, Selman M.

Arch Med Res. 1997 Summer;28(2):289-91.

PMID:
9204624
40.

A- and B-type lamins are differentially expressed in normal human tissues.

Broers JL, Machiels BM, Kuijpers HJ, Smedts F, van den Kieboom R, Raymond Y, Ramaekers FC.

Histochem Cell Biol. 1997 Jun;107(6):505-17.

PMID:
9243284
41.

Degradation of nuclear matrix and DNA cleavage in apoptotic thymocytes.

Weaver VM, Carson CE, Walker PR, Chaly N, Lach B, Raymond Y, Brown DL, Sikorska M.

J Cell Sci. 1996 Jan;109 ( Pt 1):45-56.

42.

Characterization of a novel human antibody xenoreactive with fibronectin.

Girard D, Raymond Y, Labbé P, Senécal JL.

Clin Immunol Immunopathol. 1995 Nov;77(2):149-61.

PMID:
7586722
43.

Prostate motion during standard radiotherapy as assessed by fiducial markers.

Crook JM, Raymond Y, Salhani D, Yang H, Esche B.

Radiother Oncol. 1995 Oct;37(1):35-42.

PMID:
8539455
44.

Abnormal A-type lamin organization in a human lung carcinoma cell line.

Machiels BM, Broers JL, Raymond Y, de Ley L, Kuijpers HJ, Caberg NE, Ramaekers FC.

Eur J Cell Biol. 1995 Aug;67(4):328-35.

PMID:
8521872
45.

5 alpha-Reductase type 1 is localized to the outer nuclear membrane.

Savory JG, May D, Reich T, La Casse EC, Lakins J, Tenniswood M, Raymond Y, Haché RJ, Sikorska M, Lefebvre YA.

Mol Cell Endocrinol. 1995 Apr 28;110(1-2):137-47.

PMID:
7672444
46.

Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells.

Hozák P, Sasseville AM, Raymond Y, Cook PR.

J Cell Sci. 1995 Feb;108 ( Pt 2):635-44.

47.

Lamin A precursor is localized to intranuclear foci.

Sasseville AM, Raymond Y.

J Cell Sci. 1995 Jan;108 ( Pt 1):273-85.

48.

Nuclear A-type lamins are differentially expressed in human lung cancer subtypes.

Broers JL, Raymond Y, Rot MK, Kuijpers H, Wagenaar SS, Ramaekers FC.

Am J Pathol. 1993 Jul;143(1):211-20.

49.

Autoantibodies to nuclear lamins and to intermediate filament proteins: natural, pathologic or pathogenic?

Senécal JL, Ichiki S, Girard D, Raymond Y.

J Rheumatol. 1993 Feb;20(2):211-9. Review. No abstract available.

PMID:
8474054
50.

Regulation of the expression of lamins A and C is post-transcriptional in P19 embryonal carcinoma cells.

Lanoix J, Skup D, Collard JF, Raymond Y.

Biochem Biophys Res Commun. 1992 Dec 30;189(3):1639-44.

PMID:
1282809

Supplemental Content

Loading ...
Support Center